Analyze Diet
Equine veterinary journal2026; doi: 10.1002/evj.70365

Duodenal mucosal macrophages and their role in equine inflammatory bowel disease.

Abstract: Intestinal macrophages are key regulators of gastrointestinal immune homeostasis and inflammation, yet their distribution, polarisation, and role in equine inflammatory bowel disease (IBD) remain poorly defined. Objective: (1) To assess agreement between duodenal endoscopic biopsies and paired full-thickness samples for macrophage quantification; (2) To compare duodenal macrophage polarisation between horses with and without IBD. Methods: Postmortem comparative study and case-control clinical study. Methods: Duodenal biopsies and paired full-thickness duodenal tissues were collected postmortem from 5 horses. Duodenal biopsies were performed by gastroscopy in 29 client-owned horses (IBD and control). Pan-macrophages (Iba-1) and M2 macrophages (CD204) were quantified by immunohistochemistry and histomorphometry within predefined mucosal regions. Agreement between biopsy and paired tissue was assessed using intraclass correlation coefficients (ICC) and Bland-Altman analysis. Group comparisons were performed using linear mixed models or non-parametric tests. Results: Duodenal biopsies underestimated macrophage counts. Agreement was moderate for CD204-positive macrophages across most mucosal regions (ICC 0.71-0.73; p = 0.001). Agreement for Iba-1-positive macrophages was poor, reaching significance only in the basal deep lamina propria (ICC = 0.50; p = 0.02). Horses with IBD had higher Iba-1-positive macrophage counts in the villous (70.4 ± 24.0 vs. 42.4 ± 18.1; p = 0.003) and total lamina propria (56.5 ± 23.3 vs. 38.8 ± 16.0; p = 0.03). M1 macrophage counts were greater in IBD horses in the villous (60.1 ± 5.1 vs. 20.9 ± 12.3; p = 0.002), total (48.0 ± 5.5 vs. 24.4 ± 8.5; p = 0.02), and sub-cryptal lamina propria (49.0 ± 9.4 vs. 18.6 ± 8.8; p = 0.03). Conclusions: Small sample size, no equine-specific M1 markers, and biopsy quality. Conclusions: Horses with IBD have significantly higher numbers of duodenal mucosal macrophages, highlighting their potential importance in the diagnostic interpretation and clinical management.
Publication Date: 2026-11-15 PubMed ID: 43035324DOI: 10.1002/evj.70365Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigates the presence and characteristics of macrophages, a type of immune cell, in the small intestine (duodenum) of horses with and without inflammatory bowel disease (IBD).
  • It evaluates how well less invasive biopsy samples represent full-thickness tissue samples and compares macrophage counts and types between healthy and diseased horses.

Background

  • Macrophages in the intestine play a key role in maintaining immune balance and driving inflammation.
  • In horses, the exact contribution of these cells to inflammatory bowel disease (IBD) is not well understood.
  • Understanding macrophage distribution and polarization (types/functions) could improve diagnosis and treatment of equine IBD.

Objectives

  • Compare macrophage counts obtained from less invasive duodenal endoscopic biopsies to those from full-thickness tissue samples taken postmortem to see if biopsies provide reliable data.
  • Determine differences in macrophage polarization—specifically between M2 (anti-inflammatory) and M1 (pro-inflammatory)—in the duodenal mucosa of horses with and without IBD.

Methods

  • Sample Collection:
    • Postmortem paired duodenal biopsies and full-thickness tissue samples from 5 horses to assess biopsy accuracy.
    • Duodenal biopsies via gastroscopy performed on 29 client-owned horses categorized as IBD cases or controls.
  • Macrophage Identification:
    • Pan-macrophages identified using Iba-1 immunohistochemistry marker.
    • M2 macrophages (anti-inflammatory subset) detected with CD204 marker.
    • M1 macrophages (pro-inflammatory subset) inferred by subtraction, as no equine-specific M1 markers were used.
  • Analysis:
    • Macrophages quantified within predefined layers of the mucosa by histomorphometry.
    • Intraclass correlation coefficients (ICC) and Bland-Altman analysis used to assess agreement between biopsy and full-thickness samples.
    • Linear mixed models and non-parametric tests compared macrophage counts between groups.

Key Findings

  • Duodenal biopsies generally underestimated macrophage counts compared to full-thickness samples.
  • Moderate agreement for M2 macrophages (CD204-positive) was found between biopsies and full-thickness samples (ICC 0.71-0.73).
  • Poor agreement for pan-macrophages (Iba-1-positive), except in the basal deep lamina propria where moderate correlation was detected (ICC=0.50).
  • Horses with IBD had significantly higher counts of pan-macrophages (Iba-1-positive) in the villous and total lamina propria mucosal layers compared to controls.
  • M1 macrophage counts were significantly elevated in horses with IBD across villous, total lamina propria, and sub-cryptal lamina propria mucosal regions, indicating a pro-inflammatory macrophage response.

Conclusions and Implications

  • The study highlights that duodenal mucosal macrophages, particularly pro-inflammatory M1 types, are increased in horses with IBD, suggesting their active role in disease pathology.
  • This immune cell pattern may provide useful diagnostic markers or targets for therapy in equine IBD.
  • Endoscopic biopsy samples underestimate macrophage numbers, which is important to consider in clinical evaluations.
  • Limitations include a small sample size, lack of equine-specific M1 markers, and variable biopsy quality, which could affect the accuracy and interpretation of results.

Summary

  • This research advances understanding of immune cell involvement in equine IBD by quantifying macrophage populations within the duodenal mucosa.
  • It demonstrates the challenge of relying solely on biopsy samples and emphasizes the increased abundance of pro-inflammatory macrophages in disease states.
  • Further work with larger cohorts and improved markers is needed to refine diagnostic and therapeutic approaches targeting macrophages in equine gastrointestinal health.

Cite This Article

APA
Amar A, St-Jean G, Benoit-Biancamano MO, Juette T, Wenzlow N, Jean D. (2026). Duodenal mucosal macrophages and their role in equine inflammatory bowel disease. Equine Vet J. https://doi.org/10.1002/evj.70365

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English

Researcher Affiliations

Amar, Aurélie
  • Department of Clinical Sciences, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Canada.
St-Jean, Guillaume
  • Centre de diagnostic vétérinaire de l'Université de Montréal (CDVUM), Department of Pathology and Microbiology, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Canada.
Benoit-Biancamano, Marie-Odile
  • Centre de diagnostic vétérinaire de l'Université de Montréal (CDVUM), Department of Pathology and Microbiology, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Canada.
Juette, Tristan
  • Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Canada.
Wenzlow, Nanny
  • School of Veterinary Medicine, Texas Tech University, Amarillo, Texas, USA.
Jean, Daniel
  • Department of Clinical Sciences, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, Canada.

Grant Funding

  • Equine Health Fund of the Université de Montréal
  • Fonds du Centenaire of the Université de Montréal

References

This article includes 26 references
  1. Schumacher J, Edwards JF, Cohen ND. Chronic idiopathic inflammatory bowel diseases of the horse. J Vet Intern Med 2000;14(3):258–265.
  2. Kalck KA. Inflammatory bowel disease in horses. Vet Clin North Am Equine Pract 2009;25(2):303–315.
  3. Loubière C, Moreau P, Rullier M, Hélie P, Jean D. B‐ and T‐cell lymphocytes and other immune cell infiltration in the duodenal and rectal mucosa of severe asthmatic horses. Am J Vet Res 2023;84:1–10.
    doi: 10.2460/ajvr.23.04.0083google scholar: lookup
  4. Banse HE, Piero FD, Andrews FM, Garcia‐Abarca N, Watanabe TTN. Characterization of gastrointestinal inflammatory cell type in equine glandular gastric disease. Am J Vet Res 2023;84(12):1–8.
    doi: 10.2460/ajvr.23.06.0129google scholar: lookup
  5. Kranenburg LC, Bouwmeester BF, Van Den Boom R. Findings and prognosis in 149 horses with histological changes compatible with inflammatory bowel disease. Animals (Basel) 2024;14(11):1638.
    doi: 10.3390/ani14111638google scholar: lookup
  6. Yip JLK, Balasuriya GK, Spencer SJ, Hill‐Yardin EL. The role of intestinal macrophages in gastrointestinal homeostasis: heterogeneity and implications in disease. Cell Mol Gastroenterol Hepatol 2021;12(5):1701–1718.
  7. Joeris T, Müller‐Luda K, Agace WW, Mowat AM. Diversity and functions of intestinal mononuclear phagocytes. Mucosal Immunol 2017;10(4):845–864.
    doi: 10.1038/mi.2017.22google scholar: lookup
  8. Bain CC, Schridde A. Origin, differentiation, and function of intestinal macrophages. Front Immunol 2018;9:2733.
    doi: 10.3389/fimmu.2018.02733google scholar: lookup
  9. Jones GR, Bain CC, Fenton TM, Kelly A, Brown SL, Ivens AC. Dynamics of colon monocyte and macrophage activation during colitis. Front Immunol 2018;9:2764.
    doi: 10.3389/fimmu.2018.02764google scholar: lookup
  10. Kühl AA, Erben U, Kredel LI, Siegmund B. Diversity of intestinal macrophages in inflammatory bowel diseases. Front Immunol 2015;6:613.
    doi: 10.3389/fimmu.2015.00613google scholar: lookup
  11. Michiba A, Shiogama K, Tsukamoto T, Hirayama M, Yamada S, Abe M. Morphologic analysis of M2 macrophage in glioblastoma: involvement of macrophage extracellular traps (METs). ACTA Histochem Cytochem 2022;55(4):111–118.
    doi: 10.1267/ahc.22-00018google scholar: lookup
  12. Karagianni AE, Lisowski ZM, Hume DA, Pirie SR. The equine mononuclear phagocyte system: the relevance of the horse as a model for understanding human innate immunity. Equine Vet J 2021;53(2):231–249.
    doi: 10.1111/evj.13341google scholar: lookup
  13. The WSAVA International Gastrointestinal Standardization Group, Washabau RJ, Day MJ, Willard MD, Hall EJ, Jergens AE, Mansell J. Endoscopic, biopsy, and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. J Vet Intern Med 2010;24(1):10–26.
  14. Brown CM, Slocombe RF, Derksen FJ. Fiberoptic gastroduodenoscopy in the horse. J Am Vet Med Assoc 1985;186(9):965–968.
  15. Day MJ, Bilzer T, Mansell J, Wilcock B, Hall EJ, Jergens A. Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the world small animal veterinary association gastrointestinal standardization group. J Comp Pathol 2008;138:S1–S43.
  16. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability.. Psychol Bull 1979;86(2):420–428.
  17. Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research.. J Chiropr Med 2016;15(2):155–163.
    doi: 10.1016/j.jcm.2016.02.012google scholar: lookup
  18. Packer M, Patterson‐Kane JC, Smith KC, Durham AE. Quantification of immune cell populations in the lamina propria of equine jejunal biopsy specimens.. J Comp Pathol 2005;132(1):90–95.
  19. Robel M, Grest P, Riond B, Zablotski Y, Schoster A. Quantification of immune cells in full thickness and mucosal biopsies of the duodenum and rectum in a group of slaughter horses.. J Equine Vet Sci 2025;154:105701.
  20. Rocchigiani G, Ricci E, Navarro MA, Samol MA, Uzal FA. Leukocyte numbers and intestinal mucosal morphometrics in horses with no clinical intestinal disease.. J Vet Diagn Invest 2022;34(3):389–395.
    doi: 10.1177/10406387211031944google scholar: lookup
  21. Wynn TA, Vannella KM. Macrophages in tissue repair, regeneration, and fibrosis.. Immunity 2016;44(3):450–462.
  22. Wallace KL. Immunopathology of inflammatory bowel disease.. World J Gastroenterol 2014;20(1):6.
    doi: 10.3748/wjg.v20.i1.6google scholar: lookup
  23. Caprara G, Allavena P, Erreni M. Intestinal macrophages at the crossroad between diet, inflammation, and cancer.. Int J Mol Sci 2020;21(14):4825.
    doi: 10.3390/ijms21144825google scholar: lookup
  24. Saez A, Herrero‐Fernandez B, Gomez‐Bris R, Sánchez‐Martinez H, Gonzalez‐Granado JM. Pathophysiology of inflammatory bowel disease: innate immune system.. Int J Mol Sci 2023;24(2):1526.
    doi: 10.3390/ijms24021526google scholar: lookup
  25. Lissner D, Schumann M, Batra A, Kredel LI, Kühl AA, Erben U. Monocyte and M1 macrophage‐induced barrier defect contributes to chronic intestinal inflammation in IBD.. Inflamm Bowel Dis 2015;21(6):1297–1305.
  26. Wilson ME, McCandless EE, Olszewski MA, Robinson NE. Alveolar macrophage phenotypes in severe equine asthma.. Vet J 2020;256:105436.

Citations

This article has been cited 0 times.